Promoter holding
64.27%
DP
Drakt Pharmaceuticals Pvt Ltd - Due diligence report
A 360° intelligence report on Drakt Pharmaceuticals Pvt Ltd: trust score, financial health, credit view, compliance, directors, growth and d…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Drakt Pharmaceuticals Pvt Ltd — 360° Intelligence Report
Generated from MCA filings & public records57/100
Trust Score
Moderate
Drakt Pharmaceuticals Pvt Ltd is assessed as Moderate with a Trust Score of 57/100. Drakt Pharmaceuticals Pvt Ltd is an active private limited indian non-government company incorporated in 1993, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.
Report generated on 02 Aug 2026 from the latest processed filings. Drakt Pharmaceuticals Pvt Ltd snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
57/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
55/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
40/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
50/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
- Liabilities ≈ 38% EBITDA - stretched.
- Working-capital cover adequate.
Charges position: 1 open (5.54 Lakh) · 6 satisfied (7.10 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| State Bank Of India | 7 | 48.0 cr |
Compliance Score: 55/100 Moderate
- Company status is Active as per MCA.
- Marked ACTIVE non-compliant (INC-22A).
- Last balance sheet is for Mar 2019 - filings overdue.
- 1 active GST registration(s).
05
Director Intelligence
Stability score: 55/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SWAPAN KUMAR SAHA ROY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANJOY KUMAR PAUL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BIBHAS SAHA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| JIBAN KUMAR SAHA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KANCHAN KUMAR GHOSAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RANA DASGUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUBHASH ROYCHOWDHURY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PABITRA RANJAN CHAKRABORTY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 8 directors on the board.
- JIBAN KUMAR SAHA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2017 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 50 · Distress 50
Growth signals & trust indicators
Asset base grew 1.42 - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 33+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Statutory filings appear overdue.
Compliance score is weak (55/100).
1 open charge(s) registered - assets are encumbered.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence54/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 3 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment46/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 5.54 Lakh already registered.
- Compliance gaps should be priced into terms.
Investor view48/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events09 Dec 2020
Charge satisfied
State Bank Of India
30 Sep 2019
Last AGM held
Annual general meeting
09 Apr 2019
Charge created
State Bank Of India - 5.54 Lakh
31 Mar 2019
Latest balance sheet
Filed with ROC
15 Jun 2016
Charge satisfied
State Bank Of India
14 Oct 2012
Securities allotted
140000 Equity Shares Without Differential Rights - 14.00 Lakh raised
24 Sep 2011
Charge created
State Bank Of India - 1.54 cr
14 Sep 2007
Charge created
State Bank Of India - 1.54 cr
18 May 2006
Charge created
State Bank Of India - 91.50 Lakh
18 Oct 2004
Charge created
State Bank Of India - 30.00 Lakh
03 Mar 2004
Charge created
State Bank Of India - 2.20 cr
27 Feb 2004
Charge created
State Bank Of India - 60.00 Lakh
19 May 1998
Director appointed
SWAPAN KUMAR SAHA ROY (Director)
28 Sep 1994
Director appointed
JIBAN KUMAR SAHA (Director)
Director appointed
KANCHAN KUMAR GHOSAL (Director)
10
Key Observations
Auto-generated from the data aboveRevenue declined 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
8 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Jagannath Chemical And Pharmaceutical Works Pvt Ltd | U24231OR1960PTC000391 | Cuttack, Orissa, India |
| Triumph Composites Private Limited | U23102MH1987PTC044811 | Mumbai, Maharashtra, India |
| Drg Wellness Private Limited | U51909DL2011PTC223492 | New Delhi, Delhi, India |
| Orig Pharmaceuticals Private Limited | U24232KA2015PTC078623 | Bangalore, Karnataka, India |
| Sanlar Imex Services Private Limited | U51909MH2002PTC137454 | Mumbai, Maharashtra, India |
| Sea-Shell Chemicals Private Limited | U24232UR1983PTC006025 | Uttranchal, Uttarakhand, India |
| Maa Laboratories Private Limited | U24232TG2010PTC069157 | Hyderabad, Telangana, India |
| Coastal Organics Private Limited | U24110MH1985PTC055690 | Khopoli, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Drakt Pharmaceuticals Pvt Ltd before audits and certifications: compliance score 55/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Drakt Pharmaceuticals Pvt Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Drakt Pharmaceuticals Pvt Ltd - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 57/100, distress signals and MSME payment-delay disclosures - know whether Drakt Pharmaceuticals Pvt Ltd pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Drakt Pharmaceuticals Pvt Ltd - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Drakt Pharmaceuticals Pvt Ltd an active company?
Drakt Pharmaceuticals Pvt Ltd has MCA status “Active” with a compliance score of 55/100 (Moderate).
Is Drakt Pharmaceuticals Pvt Ltd financially healthy?
Drakt Pharmaceuticals Pvt Ltd has a Financial Health Score of 40/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Drakt Pharmaceuticals Pvt Ltd?
Its overall Trust Score is 57/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Drakt Pharmaceuticals Pvt Ltd?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 8 active director(s) are on record.
Does Drakt Pharmaceuticals Pvt Ltd have loans or charges against its assets?
1 open charge(s) are registered against its assets, and 6 earlier charge(s) stand satisfied.
Is Drakt Pharmaceuticals Pvt Ltd up to date with its ROC filings?
Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 55/100 (Moderate).
Is it risky to lend to Drakt Pharmaceuticals Pvt Ltd?
Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
